Long-term follow-up of a paradigm-changing study: The paradigm still holds

Journal of Clinical Oncology

Volumn 30, Issue 16, 2012, Pages 1901-1903

  Mamon, Harvey J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PREDNISONE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHEMORADIOTHERAPY; COLON CANCER; EDITORIAL; FOLLOW UP; HUMAN; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RECTUM CANCER;

ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY; FEMALE; HUMANS; MALE; RECTAL NEOPLASMS;

EID: 84864026031     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.41.8863     Document Type: Editorial

References (22)

1. [No authors listed]: NIH consensus conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444-1450, 1990
2. Aleman BM, Bartelink H, Gunderson LL: The current role of radiotherapy in colorectal cancer. Eur J Cancer 31A:1333-1339, 1995
3. Roh MS, Colangelo LH, O'Connell MJ, et al: Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 27:5124-5130, 2009
4. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740, 2004
5. [No authors listed]: Improved survival with preoperative radiotherapy in resectable rectal cancer: Swedish Rectal Cancer Trial [erratum]. N Engl J Med 336:980-987, 1997; correction, 1539
6. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646, 2001
7. Sauer R, Liersch T, Merkel S, et al: Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30:1926-1933, 2012
8. Gunderson LL, Sargent DJ, Tepper JE, et al: Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: A pooled analysis. J Clin Oncol 22:1785-1796, 2004 (Pubitemid 41095168)
9. Miller TP, Dahlberg S, Cassady JR, et al: Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 339:21-26, 1998 (Pubitemid 28304493)
10. Miller T, Leblanc M, Spier C: CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin's lymphomas: Update of the Southwest Oncology Group (SWOG) randomized trial. Blood 98:724a-725a, 2001 (abstr 3024)
11. André T, Boni C, Mounedji-Boudiaf L, et al: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-2351, 2004 (Pubitemid 38702845)
12. Roh MS, Yothers GA, O'Connell MJ, et al: The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04. J Clin Oncol 29:221s, 2011 (suppl 15; abstr 3503)
13. Garcia-Aguilar J, Shi Q, Thomas CR Jr, et al: Pathologic complete response (pCR) to neoadjuvant chemoradiation (CRT) of uT2uN0 rectal cancer (RC) treated by local excision (LE): Results of the ACOSOG Z6041 trial. J Clin Oncol 28:263s, 2010 (suppl 15; abstr 3510)
14. Schrag D, Weiser MR, Goodman KA, et al: Neoadjuvant FOLFOX-bev, without radiation, for locally advanced rectal cancer. J Clin Oncol 28:263s, 2010 (suppl 15; abstr 3511)
15. Habr-Gama A, Perez RO, Nadalin W, et al: Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: Long-term results. Ann Surg 240:711-717; discussion 717-718, 2004
16. Maas M, Beets-Tan RG, Lambregts DM, et al: Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29:4633-4640, 2011
17. He Y, Van't Veer LJ, Mikolajewska-Hanclich I, et al: PIK3CA mutations predict local recurrences in rectal cancer patients. Clin Cancer Res 15:6956-6962, 2009
18. Salerno GV, Daniels IR, Moran BJ, et al: Magnetic resonance imaging prediction of an involved surgical resection margin in low rectal cancer. Dis Colon Rectum 52:632-639, 2009
19. Ajani JA, Mansfield PF, Janjan N, et al: Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol 22:2774-2780, 2004 (Pubitemid 41079894)
20. Ajani JA, Mansfield PF, Crane CH, et al: Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: Degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol 23:1237-1244, 2005 (Pubitemid 46202281)
21. Ajani JA, Winter K, Okawara GS, et al: Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): Quality of combined modality therapy and pathologic response. J Clin Oncol 24:3953-3958, 2006 (Pubitemid 46630744)
22. Stahl M, Walz MK, Stuschke M, et al: Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851-856, 2009